Association of serum interleukin-6 concentration with a functional IL6 -6331T>C polymorphism

Clinical Chemistry

Volumn 54, Issue 5, 2008, Pages 841-850

  Smith, Andrew J P ^a   D'Aiuto, Francesco ^b   Palmen, Jutta ^a   Cooper, Jackie A ^a   Samuel, Jane ^c   Thompson, Simon ^a   Sanders, Julie ^a   Donos, Nikos ^b   Nibali, Luigi ^b   Brull, David ^d   Woo, Pat ^c   Humphries, Steve E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Windeyer Institute   (United Kingdom)

^d WHITTINGTON HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; LUCIFERASE;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ENZYME ASSAY; GEL MOBILITY SHIFT ASSAY; GENE FREQUENCY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CELL LINE; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENES, REPORTER; GENETIC MARKERS; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-6; LINKAGE DISEQUILIBRIUM; LUCIFERASES; MIDDLE AGED; MYOCARDIAL INFARCTION; OCTAMER TRANSCRIPTION FACTOR-1; PERIODONTAL DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING;

EID: 43449128097     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.098608     Document Type: Article

References (37)

1. Pantsulaia I, Trofimov S, Kobyliansky E, Livshits G. Genetic and environmental influences on IL-6 and TNF-alpha plasma concentrations in apparently healthy general population. Cytokine 2002;19:138-46.
2. Song M, Kellum JA. Interleukin-6. Crit Care Med 2005;33(Suppl):S463-5.
3. Patel RT, Deen KI, Youngs D, Warwick J, Keighley MR. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 1994;81:1306-8.
4. Zhang GJ, Adachi I. Serum interleukin-6 concentrations correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 1999;19:1427-32.
5. Preti HA, Cabanillas F, Talpaz M, Tucker SL, Seymour JF, Kurzrock R. Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma. Ann Intern Med 1997;127:186-94.
6. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-72.
7. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, et al. Elevated concentrations of interleukin-6 in unstable angina. Circulation 1996;94:874-7.
8. Olomolaiye O, Wood NAP, Bidwell JL. A novel NlaIII polymorphism in the human IL-6 promoter. Eur J Immunogenet 1998;25:267.
9. Terry CF, Loukacis V, Green FR. Cooperative influence of genetic polymorphisms on interleukin-6 transcriptional regulation. J Biol Chem 2000;275:18138-44.
10. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, et al. Interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are strong predictors of plasma interleukin-6 concentrations after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001;21:1458-63.
11. Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, et al. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum concentrations, and the risk of relapse/recurrence in polymyalgia rheumatica. J Rheumatol 2006;33:703-8.
12. Ravaglia G, Forti P, Maioli F, Chiappelli M, Dolzani P, Martelli M, et al. Associations of the -174 G/C interleukin-6 gene promoter polymorphism with serum interleukin 6 and mortality in the elderly. Biogerontology 2005;6:415-23.
13. Walston J, Arking DE, Fallin D, Li T, Beamer B, Xue Q, et al. IL-6 gene variation is not associated with increased serum concentrations of IL-6, muscle, weakness, or frailty in older women. Exp Gerontol 2005;40:344-52.
14. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 concentrations, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76.
15. Malarstig A, Wallentin L, Siegbahn A. Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome. Thromb Res 2007;119:467-73.
16. Fife MS, Ogilvie EM, Kelberman D, Samuel J, Gutierrez A, Humphries SE, Woo P. Novel IL-6 haplotypes and disease association. Genes Immun 2005;6:367-70.
17. D'Aiuto F, Nibali L, Mohamed-Ali V, Vallance P, Tonetti MS. Periodontal therapy: a novel nondrug-induced experimental model to study human inflammation. J Periodontal Res 2004;39:294-9.
18. D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005;84:269-73.
19. D'Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J 2006;151:977-84.
20. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007;356:911-20.
21. Juhan-Vague I, Morange PE, Aubert H, Henry M, Aillaud MF, Alessi MC, et al., on behalf of the HIFMECH Study Group. Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe. Arterioscler Thromb Vasc Biol 2002;22:867-73.
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Vols. 1-3. New York: Cold Spring Harbor Laboratory Press, 1989.
24. Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL. A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet 2004;68(Pt 2):165-77.
25. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73:1162-9.
26. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 2000;148:209-14.
27. Haddy N, Sass C, Droesch S, Zaiou M, Siest G, Ponthieux A, et al. IL-6, TNF-alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. Atherosclerosis 2003;170:277-83.
28. Worns MA, Victor A, Galle PR, Hohler T. Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 concentrations - a study in twins. Genes Immun 2006;7:600-5.
29. D'Aiuto F, Casas JP, Shah T, Humphries SE, Hingorani AD, Tonetti MS. C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis 2005;179:413-7.
30. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-6.
31. Müller-Steinhardt M, Ebel B, Hartel C. The impact of interleukin-6 promoter(-597/-572/-174) genotype on interleukin-6 production after lipopolysaccharide stimulation. Clin Exp Immunol 2007;147:339-45.
32. Hohjoh H, Tokunaga K. Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter. Genes Immun 2001;2:105-9.
33. Ullman KS, Flanagan WM, Edwards CA, Crabtree GR. Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40. Science 1991;254:558-62.
34. Kaushansky K, Shoemaker SG, O'Rork CA, Mc-Carty JM. Coordinate regulation of multiple human lymphokine genes by Oct-1 and potentially novel 45 and 43 kDa polypeptides. J Immunol 1994;152:1812-20.
35. Wu GD, Lai EJ, Huang N, Wen X. Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter. The role of Oct-1 as a transcriptional repressor. J Biol Chem 1997;272:2396-403.
36. Kilger E, Weis F, Briegel J, Frey L, Goetz AE, Reuter D, et al. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003;31:1068-74.
37. Hedman A, Larsson PT, Alam M, Wallen NH, Nordlander R, Samad BA. CRP, IL-6 and endothelin-1 concentrations in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events? Int J Cardiol 2007;120:108-14.